Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT03419260
- Status
- Recruiting
Conditions
- Seizures
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Month - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Clinically indicated EEG monitoring. — OTHERChildren enrolled in the study will be undergoing clinically indicated EEG monitoring. Some children will undergo clinically indicated electrographic seizure management.
Study Details
Electrographic seizures are common in critically ill patients leading to increased use of resource-intense continuous EEG monitoring for seizure identification and management. When identified, electrographic seizures are generally treated with anti-seizure medications, but there are very limited data available regarding optimal treatment in terms of the efficacy or safety of specific anti-seizure medications or overall management strategies. This is a single-center prospective observational study. The investigators aim to: (1) track critically ill patients undergoing clinically indicated EEG monitoring and seizure management to identify risk factors for electrographic seizures, (2) create prediction models guiding EEG monitoring resources to the patients at highest risk for seizures, and (3) evaluate our current management strategy in terms of safety.
Key Dates
- Start date
- Mar 13, 2017
- Status verified
- Feb 2025
- Primary completion
- Jan 1, 2027
- Completion
- Jan 1, 2027
Study Design
- Enrollment
- 2,500 participants (estimated)
Arms
- Arm: CohortCritically ill child undergoing clinically indicated EEG monitoring and electrographic seizure management.
Primary Outcome Measure
Electrographic Seizure Occurrence [ Time Frame: 3 days ]
Central Contacts
- Nicholas S Abend, MD215-590-1719
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Nichoals S Abend, MD 215-590-1719 |
Find similar trials in Philadelphia, PA
Related Studies
- Pediatric Dose Optimization for Seizures in Emergency Medical ServicesPHASE3 · Recruiting · Stanford University · Tucson, Arizona
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsPHASE3 · Recruiting · SK Life Science, Inc. · Palo Alto, California
- Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in EpilepsyRecruiting · University of Florida · Gainesville, Florida
- Genetic Markers of Cardiovascular Disease in EpilepsyRecruiting · Mayo Clinic · Rochester, Minnesota